BOSTON SCIENTIFIC CORP Cash & Equivalents 2006-2026 | BSX
What is cash & equivalents?
Cash and cash equivalents can be defined as the most liquid assets on a company's balance sheet, including cash on hand and short-term investments maturing within 90 days.
What is BOSTON SCIENTIFIC CORP's current cash & equivalents?
BOSTON SCIENTIFIC CORP (BSX) annual cash & equivalents for 2025 was $1.97B, a 374.64% increase from 2024. BOSTON SCIENTIFIC CORP cash & equivalents for the quarter ending March 31, 2026 was $1.45B.
What was BOSTON SCIENTIFIC CORP's cash & equivalents in 2024?
BOSTON SCIENTIFIC CORP annual cash & equivalents for 2024 was $414.0M, a 52.14% decline from 2023.
What was BOSTON SCIENTIFIC CORP's cash & equivalents in 2023?
BOSTON SCIENTIFIC CORP annual cash & equivalents for 2023 was $865.0M, a 6.79% decline from 2022.
What is BOSTON SCIENTIFIC CORP's 5-year cash & equivalents CAGR?
BOSTON SCIENTIFIC CORP cash & equivalents grew at a compound annual growth rate (CAGR) of 2.53% from FY2020 to FY2025, going from $1.73B to $1.97B over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $1.97B | +374.6% | 10-K |
| FY2024 | $414.0M | -52.1% | 10-K |
| FY2023 | $865.0M | -6.8% | 10-K |
| FY2022 | $928.0M | -51.8% | 10-K |
| FY2021 | $1.93B | +11.0% | 10-K |
| FY2020 | $1.73B | +699.1% | 10-K |
| FY2019 | $217.0M | +48.6% | 10-K |
| FY2018 | $146.0M | -22.3% | 10-K |
| FY2017 | $188.0M | -4.1% | 10-K |
| FY2016 | $196.0M | -38.6% | 10-K |
| FY2015 | $319.0M | -45.7% | 10-K |
| FY2014 | $587.0M | +170.5% | 10-K |
| FY2013 | $217.0M | +4.8% | 10-K |
| FY2012 | $207.0M | -22.5% | 10-K |
| FY2011 | $267.0M | +25.4% | 10-K |
| FY2010 | $213.0M | -75.3% | 10-K |
| FY2009 | $864.0M | -47.3% | 10-K |
| FY2008 | $1.64B | +13.0% | 10-K |
| FY2007 | $1.45B | -12.9% | 10-K |
| FY2006 | $1.67B | - | 10-K |